Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 167.3 | 177.3 | 173.0 | 166.0 |
| Revenue growth | -5.7% | 2.5% | 4.2% | |
| Cost of goods sold | 100.8 | 99.3 | 88.9 | 0.0 |
| Gross profit | 66.4 | 78.0 | 84.1 | 166.0 |
| Gross margin | 39.7% | 44.0% | 48.6% | 100.0% |
| Selling, general and administrative | | | | 0.2 |
| Sales and marketing | 30.6 | 33.8 | 28.7 | |
| Research and development | 61.4 | 63.4 | 52.9 | |
| General and administrative | 40.1 | 40.9 | 16.6 | |
| EBITA | -65.6 | -60.1 | -14.1 | 166.0 |
| EBITA margin | -39.2% | -33.9% | -8.1% | 100.0% |
| Amortization of intangibles | 1.1 | 1.2 | 1.7 | |
| EBIT | -66.7 | -61.3 | -15.8 | 166.0 |
| EBIT margin | -39.9% | -34.6% | -9.1% | 100.0% |
| Pre-tax income | -85.6 | -71.2 | -26.4 | 51.5 |
| Income taxes | 0.2 | 0.7 | 0.8 | -0.5 |
| Net income | -85.4 | -70.5 | -25.6 | 0.0 |
| Net margin | -51.0% | -39.8% | -14.8% | 0.0% |
| |
| Diluted EPS | ($1.17) | ($1.09) | ($0.43) | $0.00 |
| Shares outstanding (diluted) | 72.8 | 64.5 | 59.7 | 0.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|